Xvir Therapeutics GmbH - YB-1 dependent oncolytic adenoviruses

<body bgcolor="#FDF0DE">  <b><H1>YB-1 oncolytic adenovirus cancer therapy</H1></b> <b><H2>Cancer Therapy, oncolytic dependent Onkolytische Viren, Krebstherapie Krebsforschung Krebsbekämpfung</H2><br></b> <br> YB-1 dependent oncolytic adenoviruses virus Krebsforschung Cancer Therapie therapy <a href="http://www.xvir.com">YB-1 oncolytic adenovirus cancer therapy</a> </body>


	[ News ]

Welcome to Xvir® Therapeutics

Xvir® Therapeutics GmbH is a biopharmaceutical company, which provides YB-1 dependent oncolytic adenoviruses for the treatment of cancer and in particular multidrug-resistant cancer.

Detailed information about the company will be up shortly right here with the Xvir-website! Sign up here if you wish to be informed when the site is launched:

Your first name:
Your last name:
Your eMail-address: